SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,424,544 | +14.8% | 191,373 | +30.2% | 0.05% | +13.0% |
| Q2 2023 | $3,854,340 | -89.7% | 147,000 | -89.8% | 0.05% | -90.9% |
| Q1 2023 | $37,255,793 | +183.1% | 1,447,389 | +520.6% | 0.51% | +136.9% |
| Q1 2022 | $13,162,000 | -12.4% | 233,210 | -3.8% | 0.21% | -0.5% |
| Q4 2021 | $15,024,000 | +1678.0% | 242,400 | +1719.0% | 0.22% | +1435.7% |
| Q3 2021 | $845,000 | -89.3% | 13,326 | -86.0% | 0.01% | -90.5% |
| Q2 2021 | $7,867,000 | -39.0% | 95,458 | -45.6% | 0.15% | -48.6% |
| Q1 2021 | $12,899,000 | +37.0% | 175,328 | +35.0% | 0.29% | +14.4% |
| Q4 2020 | $9,415,000 | -11.2% | 129,832 | -41.6% | 0.25% | -28.0% |
| Q3 2020 | $10,601,000 | +55.3% | 222,376 | +36.8% | 0.35% | +28.5% |
| Q2 2020 | $6,826,000 | +19.9% | 162,515 | -22.9% | 0.27% | -33.7% |
| Q1 2020 | $5,694,000 | – | 210,893 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |